>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • LUNR +47.6%, IAUX +6.5%, BAK +3.3%, QTRX +3.2%, GLNG +3.1%, EWTX +2.6%, CMPO +2.5%, ACHR +1.9%, RUN +1.8%, CRM +1%, MNKD +0.9%, BJ +0.8%
  • Gapping down:
    • CBUS -16.8%, CWST -3.5%, MOD -1.8%, MASI -1.7%, BOX -1.3%, PHR -0.9%, LBPH -0.8%, ALK -0.6%

FT : Private equity suitors line up for Bausch + Lomb eyecare auction

Private equity suitors line up for Bausch + Lomb eyecare auction
Sale process comes after tensions between investors and creditors over plan to split from Bausch Health

Blackstone, Advent International and TPG Capital are among a long list of private equity firms studying bids for Bausch + Lomb, according to people close to the discussions, after the eyecare company kicked off a sale process to break the impasse over a spin-off from its indebted parent.

Bausch + Lomb was put up for sale after a planned separation from its parent company Bausch Health, formerly known as Valeant, unravelled amid tensions between activist investors and creditors owed $21bn by the parent company.

Private equity groups KKR, CVC Capital and Hellman & Friedman are also considering bids for the eyecare business, ahead of a soft deadline later this week, according to people familiar with the matter.

The firms have held meetings with Bausch + Lomb’s management team — which is led by chief executive Brent Saunders, a well-known dealmaker — in recent weeks, they added.

Potential bidders will have to express interest in making an offer by Friday to stay in the process, people familiar with the matter said. There is no guarantee that the sale process will result in a deal. Bausch Health is also exploring other options, including refinancing some of its debt.

Bausch + Lomb, which is being advised by Goldman Sachs, wants to enter into exclusive talks over a possible sale by the end of October. A target sale price for the business could not be ascertained, but is likely to come at a premium to the current enterprise value including debt of $11.5bn.

TPG is particularly interested in Bausch + Lomb as it could extract synergies with BVI Medical, an ophthalmology company it already owns, one person said.

Bausch + Lomb and Goldman Sachs as well as Advent, Blackstone, H&F, KKR and TPG declined to comment. Bausch Health and CVC did not immediately respond to a request for comment.

After announcing a spin-off four years ago, Bausch + Lomb was listed as a separate company in 2022 but Bausch Health retained an 88 per cent shareholding. Because of concerns from lenders over the health of Bausch Health’s balance sheet, the original plan to strike a deal with investors to exchange Bausch Health stock for Bausch + Lomb came undone.


Bausch Health creditors, including Apollo Management, Elliott Management, GoldenTree Asset Management and Silver Point Capital, opposed a spin-off over concerns that it could leave the parent company insolvent, as it would lose its more profitable subsidiary just ahead of roughly $10bn worth of maturities coming due before the end of 2027.

In contrast, Bausch Health’s top shareholders, activist investor Carl Icahn and John Paulson’s fund Paulson & Co, who have board representation at both the parent company and its subsidiary, had supported the completion of a spin-off as it would give them a large shareholding in the more profitable eye care business. A sale, however, could satisfy both parties, as it would realise a sizeable return for shareholders and give Bausch Health cash to pay its debts.

Bausch + Lomb is projected to generate nearly $860mn in adjusted earnings before interest, taxation, depreciation and amortisation from $4.7bn in revenues this year, nearly three-fifths of which comes from sales of contact lenses and dry eye drugs Xiidra and Miebo. The company also sells surgical equipment to ophthalmologists.

Since the Financial Times reported over the weekend that Bausch + Lomb was working with advisers to test interest from private equity buyers, its share price has increased 19 per cent, valuing its equity at $6.5bn as of Tuesday’s market close.

David Saxon, a Needham analyst, said in a note earlier this week that he believed private equity was “the most likely buyer”. But he added that “it is uncertain a [Bausch + Lomb] sale would alleviate investors’ concerns around [Bausch Health’s] solvency and could be challenged by [Bausch Health’s] creditors.”

Bausch Health faces further uncertainty as its lead drug — Xifaxan, a gastrointestinal medication — is set to come off patent by 2029. Bausch Health’s market value has risen by 13 per cent to $2.6bn this week, but remains below its value before the company faced legal challenges over its Xifaxan patents.

FT : The FTC’s fight to stop an $8.5bn American fashion takeover

The FTC’s fight to stop an $8.5bn American fashion takeover
Michael Kors among those called to testify as regulators try to block a deal between the owners of Coach and his brand

Michael Kors debuted his latest collection at New York Fashion Week last Tuesday before a star-studded crowd including Vogue’s Anna Wintour. Just blocks away, the curtain rose on a different spectacle involving the brand.

At a courthouse in lower Manhattan, the owners of Michael Kors and Coach were fighting to allow a multibillion-dollar merger that would put several household-name fashion brands under one roof.

Tapestry — which owns Coach, Kate Spade and Stuart Weitzman — agreed last year to purchase Capri — the owner of Michael Kors, Versace and Jimmy Choo — as many fashion brands endured a slump in sales following the pandemic’s shopping mania.

Yet the proposed deal for Capri has been stuck in limbo since the Federal Trade Commission sued to block the $8.5bn combination five months ago. The trial in Manhattan this month will help determine if the takeover can go through as planned.

Experts believe it is the first major antitrust case to hit the fashion industry, a sector notorious for shifting trends and fortunes. If regulators are successful in thwarting the union, it could have damning implications for fashion houses globally, and would stymie the kinds of serial acquisitions such as those that built European behemoths including LVMH and Kering.

Any client who is interested in buying a clear competitor, even if there are many others in the market, would have major regulatory risk, said George Paul, a partner at White & Case.

“If there’s that kind of language in your documents, no matter what the product market is, you have to be concerned that you’ll get sued” should the regulator win this case, he said. “Because as long as they’re close substitutes, the FTC seems to be discounting the consumer’s ability to actually make the switch” to other brands.

Regulators have built their case around a slice of the market they define as “accessible luxury”: handbags that are relatively affordable but good quality, and that are typically priced between $100 and $1,000. They argue the merger would result in higher prices for consumers and a lower quality in products, “leading to undue concentration and a presumption of illegality”, according to court filings, because a few of the brands compete head-to-head.

Yet the companies insist today’s handbag market is replete with competition. Their witnesses have testified that not only are there hundreds of other brands, but shoppers of varying incomes buy bags at all different prices. Coach and Michael Kors are not just jockeying for sales with other companies in their price bracket — they are also competing against everyone from high-end Celine to eBay.

While the trial is a precursor to further official proceedings, the court’s decision is expected to be pivotal, because the merger needs to close by February. The final witness testimony wrapped up this week, and each side will give closing arguments on September 30. US district judge Jennifer Rochon, who is hearing the case, will make a decision sometime in the next few months on whether to freeze the deal.

Since Lina Khan took the helm of the FTC in 2021, the agency has not shied away from seeking to block big deals, taking bold swings at tie-ups between Nvidia and chip designer Arm, grocery giants Kroger and Albertsons and biotech company Illumina and cancer screening start-up Grail.

“The law doesn’t distinguish between which markets are deserving of competition and innovation,” said Lee Hepner, senior counsel for the American Economic Liberties Project, a think-tank.

If the FTC succeeds in preventing the deal “there might be interesting implications for the fashion industry itself, but really those implications and the preservation of competition and innovation will have ripple effects across markets and industries,” he added.

While Tapestry and Capri are at the centre of the case, they are not the only ones that have featured in the trial. Other global fashion brands including Prada, Chanel and athletic brand Lululemon have been drawn into the proceedings, with many of them subpoenaed to supply documents, expert testimony, or both.

Joanne Crevoiserat, Tapestry’s chief executive, testified for nearly three hours last week in front of a packed courtroom. Next to the witness stand stood beige rolling carts bearing dozens of handbags — which served as legal exhibits.

A lawyer for the company prompted Crevoiserat to hold up a couple of the company’s products before the court to show their differences. She displayed the Coach Rogue bag, which can go for $1,095, and a white-and-green chequered Kate Spade purse. “I could maybe sell some handbags today,” she quipped.

Crevoiserat said competition between the brands would persist even if they fell under the same ownership. “The deal simply wouldn’t pencil if all brands could not grow,” she added.

The case has also put a spotlight on the ever-changing nature of the market for purses, as even rich consumers are turning to popular affordable options such as Trader Joe’s $2.99 mini-tote bag and Lululemon’s $38 “belt bag”. Social media — where new entrants can sell directly to consumers — and the resale market have also dramatically altered the landscape.

“What really pains me is that even my own daughter carries one,” Crevoiserat said, referring to the Lululemon bag.

While there are many competitors, regulators have tried to show that together, Michael Kors, Kate Spade and Coach dominate the market, occupying “well over 50 per cent in the sale of ‘accessible luxury’ handbags in the United States”.

Yet pinning down exactly how consumers buy fashion accessories will prove a steep hurdle. “It’s obviously very difficult to determine to what extent brands compete with one another,” said one former federal antitrust enforcer. “Consumer tastes are very complicated and fashions change. So it’s the kind of case that really doesn’t sit well with the binary logic of market definitions.”

Because both companies are publicly traded, their share prices throughout the trial reflect investors’ confidence that the deal will go through, which would involve Tapestry buying Capri for $57 a share — a roughly 40 per cent premium to where the stock currently trades. Both companies’ shares have climbed since the trial began.

Michael Kors, which was founded in 1981, is one example of a brand that has struggled to keep up. In some antitrust defences, companies will try to argue that one of the businesses needs a merger in order to survive, called the “failing firm defence”.

While Michael Kors is not in a dire financial state, lawyers for Tapestry and Capri have argued its historic strength has recently fizzled.

“This market is so competitive that [Michael Kors] is just not competitively relevant in any unique way,” said one adviser close to Tapestry’s thinking. “And there’s no indication that’s going to improve anytime soon.”

Michael Kors himself testified earlier this week to address how the brand has evolved since he founded it more than four decades ago, and where it stands today. He said the company had suffered from “brand fatigue” recently, and its attempts to re-energise consumers had hit “stasis at this point”.

“When you’ve been a designer for 45 years, it’s a very cyclical business,” Kors said, referring to the industry at large. “Sometimes you’ll be the hottest thing on the block, sometimes you’ll be lukewarm, and sometimes you’ll be cold.”

FT : British Steel reveals eightfold increase in losses

British Steel reveals eightfold increase in losses
Concerns mount about future of Chinese-owned company that employs thousands in UK

British Steel has announced an eightfold increase in pre-tax losses during 2022 as concerns mount about the future of the Chinese-owned company.

The steelmaker, owned by China’s Jingye, made losses of £408mn on turnover of £1.7bn in the 12 months to December 2022, according to newly filed accounts at Companies House. A year earlier, it lost £49.5mn on turnover of £1.5bn.

The UK government has been in long-running talks with the company to help fund its transition from conventional steelmaking to greener, less labour-intensive electric arc furnaces. Ministers are aiming for a similar deal to one they struck with Tata Steel last week, which secured £500mn of state aid for the UK’s largest steelworks. 

But with no agreement in sight, one person close to the situation said the government expected Jingye to announce the closure of its two blast furnaces in Scunthorpe this month, with potentially thousands of job losses. 

British Steel said discussions were “ongoing” with the government about potential support for its decarbonisation programme and the future operations of the business. “While we have invested more than £1bn to maintain our ageing blast furnaces, this is not financially or environmentally sustainable for the longer term,” it said.

>>> Europe : Brokers Upgrades & Downgrades - 18th of September 2024 V2(+)

>>> Up
* BMW Raised to Neutral at Citi; PT 74 euros
* Commerzbank Raised to Equal-Weight at Barclays; PT 16 euros
* Domino's Pizza Group Raised to Neutral at Redburn
* Hammerson Raised to Buy at Citi; PT 43 pence
* Iberdrola Raised to Buy at Bestinver; PT 14.40 euros
* InterContinental Hotels Raised to Buy at Goldman; PT 9,350 pence
* Kainos Raised to Buy at Deutsche Bank (+)
* Lancashire Raised to Buy at Goldman; PT 750 pence
* Team17 Raised to Overweight at Cantor; PT 270 pence
* Thule Raised to Hold at Nordea
* Ubisoft Raised to Outperform at BMO; PT 22 euros (+)
* Victoria's Secret Raised to Equal-Weight at Barclays; PT $25

>>> Down
* BNP Paribas Cut to Hold at HSBC; PT 70 euros
* Bufab Cut to Hold at SEB Equities; PT 420 kronor
* Edwards Life Cut to Hold at Jefferies; PT $70
* EQT Cut to Sell at UBS (+)
* Lonza Cut to Hold at Intron Health; PT 550 Swiss francs (+)
* Sampo Cut to Sell at Goldman; PT 40.50 euros
* Sonova Cut to Equal-Weight at Barclays; PT 310 Swiss francs
* Spectris Cut to Hold at HSBC; PT 3,050 pence

>>> Initiation
* Ackermans Rated New Buy at Berenberg; PT 236 euros
* BeiGene ADRs Rated New Market Outperform at JMP; PT $288
* Canatu Rated New Reduce at Inderes; PT 13 euros
* Enad Global 7 Reinstated Hold at Kepler Cheuvreux; PT 14 kronor (+)
* Hiscox Cut to Neutral at Goldman; PT 1,265 pence
* Hornbach Holding Rated New Add at Baader Helvea; PT 95 euros
* Maasoeval Rated New Hold at Arctic Securities; PT 35 kroner
* Marshalls Rated New Sector Perform at RBC; PT 370 pence
* Note Rated New Buy at Pareto Securities; PT 165 kronor
* SigmaRoc Rated New Outperform at Davy; PT 105 pence (+)

>>> Call

>>> Stoxx 600 Pre-Market Indications

  • BMW (BMW TH) +1.8%
    • BMW Raised to Neutral at Citi; PT 74 euros
  • Ubisoft (UEN TH) +1.4%
    • Ubisoft Raised to Outperform at BMO; PT 22 euros
  • Veolia (VVD TH) -0.8%
  • Adyen (1N8 TH) -0.8%
  • Talanx (TLX TH) -1%
  • Rio Tinto (RIO1 TH) -1.2%
    • Rio Tinto Turns to Farming in Quest to Curb Polluting Diesel
  • BAE (BSP TH) -1.5%
    • Morgan Stanley Positive on European Defense Stocks After Slump
  • Novo (NOV TH) -1.9%
    • Novo Says Ozempic ‘Very Likely’ Target for Next US Price Cut (1)

>>> Europe : Brokers Upgrades & Downgrades - 18th of September 2024

>>> Up
* BMW Raised to Neutral at Citi; PT 74 euros
* Commerzbank Raised to Equal-Weight at Barclays; PT 16 euros
* Domino's Pizza Group Raised to Neutral at Redburn
* Hammerson Raised to Buy at Citi; PT 43 pence
* Iberdrola Raised to Buy at Bestinver; PT 14.40 euros
* InterContinental Hotels Raised to Buy at Goldman; PT 9,350 pence
* Lancashire Raised to Buy at Goldman; PT 750 pence
* Team17 Raised to Overweight at Cantor; PT 270 pence
* Thule Raised to Hold at Nordea
* Victoria's Secret Raised to Equal-Weight at Barclays; PT $25

>>> Down
* BNP Paribas Cut to Hold at HSBC; PT 70 euros
* Bufab Cut to Hold at SEB Equities; PT 420 kronor
* Edwards Life Cut to Hold at Jefferies; PT $70
* Sampo Cut to Sell at Goldman; PT 40.50 euros
* Sonova Cut to Equal-Weight at Barclays; PT 310 Swiss francs
* Spectris Cut to Hold at HSBC; PT 3,050 pence

>>> Initiation
* Ackermans Rated New Buy at Berenberg; PT 236 euros
* BeiGene ADRs Rated New Market Outperform at JMP; PT $288
* Canatu Rated New Reduce at Inderes; PT 13 euros
* Hiscox Cut to Neutral at Goldman; PT 1,265 pence
* Hornbach Holding Rated New Add at Baader Helvea; PT 95 euros
* Maasoeval Rated New Hold at Arctic Securities; PT 35 kroner
* Marshalls Rated New Sector Perform at RBC; PT 370 pence
* Note Rated New Buy at Pareto Securities; PT 165 kronor

>>> Call

>>> What to look at today - 18th of september 2024

The dollar fell, resuming this month’s downtrend, as traders debated the size of a potential Federal Reserve interest-rate cut later Wednesday. Japanese shares pared earlier gains as the yen strengthened.  Bloomberg’s dollar index dropped for the fifth time in six days as market-implied odds put the chance of a half-point Fed rate cut Wednesday at just over 50%. The central bank will also release its long-term dot-plot forecasts with the decision, and Chair Jerome Powell will hold a press conference.  Japanese stocks retraced earlier gains as the yen rebounded in Asia from its weakness on Tuesday, hurting the outlook for the nation’s exporters. Other Asian shares were mixed while US stock futures crept higher with investors unwilling to place big bets before the Fed. Treasuries were little changed.  Traders who are locked into record wagers tied to the Fed’s expected rate cut Wednesday are risking sharp losses if officials opt for a standard-sized reduction. In some markets, investors are primed for further easing from their local central banks in anticipation that the Fed will take more aggressive action to head off a slowdown. Bloomberg’s dollar gauge slipped 0.1%, extending losses over the past week to almost 1%. The yen climbed about 0.7% after sinking more than 1% in New York. Bank of Japan Governor Kazuo Ueda and his colleagues are forecast to keep rates hold on Friday and discuss whether conditions are falling into place for another hike this year. Chinese chip-related stocks jumped after the nation claimed a breakthrough in the development of homegrown chip-making equipment. Shanghai Zhangjiang High-Tech Park Development jumped by the daily 10% limit, while Changchun UP Optotech and Sai Micro Electronics also rallied. What Powell says in his press conference about the state of the US economy may help build confidence for those worried about a recession in the near term, according to Kristina Hooper at Invesco, who expects the Fed to cut by 25 basis points. Oil edged lower after a two-day gain as traders assessed indications of higher US stockpiles, rising tensions in the Middle East, and the likely course of the Federal Reserve’s rate path. Crude jumped Tuesday after thousands were hurt in what Hezbollah labeled an attack by Israel involving pagers in Lebanon. US After Hours LUNR +32.6% wins NASA contract; BLK, MSFT and others launch new AI infrastructure fund.

Nikkei +0.17% Hang Seng Closed CSI -0.12% Shanghai -0.15% Shenzen -0.97%

Eur$ 1.1123 CNH 7.0970 CNY 7.0960 JPY 141.38 GBP 1.3162 CHF 0.8453 RUB 91.5717 TRY 34.0681 WTI$ 70.89 -0.42% Gold 2,571 +0.06% BTC 60,476 +0.56% ETH 2,327 -0.76%

S&P +0.07% Nasdaq +0.07% EuroStoxx -0.04% FTSE -0.27% Dax -0.09% SMI +0.05%

Macro :
- Scaramucci Expects Bitcoin Record on Rate Cuts, Clearer US Rules
- EU competition chief warns against weakening rules to create champions
- STEVE COHEN STOPS TRADING FOR POINT72, WILL REMAIN CO-CIO
- Switzerland’s SIX explores launching crypto exchange

Keep an eye on :
- ACS SM : ACS enters the bidding for Asterion and Telefónica data centers
- ACS SM : ACS’s Iridium Among Final Bidders to Buy Nabiax: Expansion
- AIR FP : Indonesian Air Force Orders Four Airbus H145 Helicopters
- AF FP : Air France Suspends Flights Between Paris and Beirut, Tel Aviv
- AMS LN : Inflexion Mulls Takeover of AMS Group: Sky News
- BEIJB SS : Beijer Ref Holder EQT Offers About 20m Shares: Terms, placed @ SEK165/share
- BOX US : Box Prices $400m Convertible Senior Notes Offering (1)
- BP/ LN : Exxon, BP Scenarios Expect Peak Carbon In Next Few Years: BNEF
- BRBY LN : Burberry Desperately Needs the Return of Britpop: Andrea Felsted
- ALCAR FP : Carmat to Raise EU10.3M in Capital Increase
- CON GY : Continental Is Said to Push Ahead With Pitches for Auto Spinoff
- DOV IM : doValue Reverse Stock Split to Take Place Sept. 23
- ELO NO : Elopak Offering of 20m Shares by Holder Prices at NOK41/Share
- FDJ FP : FDJ Brings Forward Expiry of Kindred Offer Acceptance Period
- G IM : Assicurazioni Generali Reaches Deal to Sell Turkish Business
- HTRO SS : Hexatronic Group CEO Henrik Larsson Lyon to Depart
- MSFT US : BlackRock and Microsoft plan $30bn fund to invest in AI infrastructure
- MB IM : Partners Group Forms Partnership With Mediobanca Private Banking
- MBTN SW : Meyer Burger CEO, CFO Stepping Down Amid Restructuring
- MBTN SW : Solar Panel Maker Meyer Burger to Cut Jobs, Sacks Top Executives
- MSTR US : MicroStrategy Said to Raise $875M in Upsized Convertible Issue
- MONC IM : Moncler Holder Grinta Offers 2.29m Shares via JPMorgan, Moncler Offering by Rivetti Prices at EU49.80/Share: Terms
- 5401 JP : NIPPON STEEL SAID TO WIN EXTENSION FOR REVIEW OF US STEEL DEAL
- NOVN SW : Novartis Early Breast Cancer Treatment Kisqali Wins FDA Approval
- NVDA US : Nvidia Recently Discussed Acquiring Software Startup OctoAI for $165 Million
- PNDXB SS : Pandox Offers SEK2 billion Shares, Pandox Offering of 10.8m Shares Prices at SEK186/Share
- PGHN SW : Partners Group Forms Partnership With Mediobanca Private Banking
- RKT LN : Reckitt Said to Start Talks on £6 Billion Homecare Assets Sale
- SCATC NO : Scatec Offering by Holder Prices at NOK80.50/Share
- STR AV : Strabag Says Rasperia Stake Reduction Binding After Court Ruling
- STLA US : UAW to Hold Strike Authorization Votes Against Stellantis (1)
- TUP US : TUPPERWARE FILES BANKRUPTCY AFTER FAILED TURNAROUND EFFORT
- X US : U.S. Steel C.E.O. Says Nippon Deal Will Strengthen National Security
- VLA FP : Valneva Submits Label Extension Applications for Chikungunya Jab